At Long Last, FDA Unveils Plan for Rare Disease Innovation Hub
FDA Law Blog
JULY 17, 2024
According to FDA, the new Hub will have special focus on products intended for smaller populations and also for diseases where the natural history is variable and not fully understood. clinical pharmacology/biomarkers, animal models, real-world evidence and other externally controlled comparisons [e.g.,
Let's personalize your content